hero-bg

IQN Path cfDNA Multi-Target Testing Pilot Scheme

IQN Path plans to deliver an external quality assessment (EQA) for testing plasma samples for the detection of multiple targets. You are invited to complete a short online survey to determine the targets currently tested, understand the research and developments underway and plans for future implementation of multiple targets.

The survey can be accessed by clicking the link below and will close on 31st July 2021.

New Pilot EQA Scheme – Rare Neurological Diseases (RND)

EMQN and ERN-RND are collaborating to provide a new pilot RND EQA. Samples for this pilot will be distributed Autumn 2021 and will be suitable for laboratories running a rare neurological disease panel, clinical exome or WGS.

Please contact office@EMQN.org quoting your EMQN participant number and 'RND pilot EQA' in the subject line to participate. Closing date for applications is 18th July 2021. Places will be offered on a first-come-first-served basis. Costs of participation will be £305.

EQAs for SARS-Cov-2 and other respiratory viruses open for registration

We have EQAs for SARS-Cov-2 only, or in conjunction with other major respiratory viruses (RSV, Influenza) available for registration. Use the button below to browse our scheme catalogue.

We are a not-for-profit organisation promoting quality in genetic testing by establishing, harmonising and disseminating best practice.

We provide ISO 17043 accredited External Quality Assessment (EQA) or Proficiency Testing (PT) schemes which are designed to test the whole analytical process of a molecular diagnostics laboratory including the ability to interpret data in the light of clinical information supplied with a referral, and to produce a clear and accurate report.

    Membership

    Membership of EMQN gives your laboratory access to world class resources in genomics to help improve your performance.

    EMQN Membership

    Best Practice

    We facilitate the development and publication of best practice guidelines. To participate in a best practice meeting you must be a registered member of the network.

    Best Practice with EMQN

    The latest news and press releases

    Posted 2 months ago

    IQNPath webinar: Standardization in TMB Assessment: How far we are

    EMQN recently collaborated with IQNPath on a project to assess standardisation of Tumour Mutation Burden (TMB) testing.   If you…
    Posted 2 months ago

    LIVE Webinar - lessons learned from the 2020 ovarian and prostate cancer EQA schemes

    On Wednesday 19th May 2021 at 13:00 – 14:00 BST (12:00 GMT) Professor Sandi Deans (GenQA) and Dr Simon Patton (EMQN)…
    Translate »